Market Cap | ₹171Cr |
ROE | 2.51% |
P/E Ratio(TTM) | 0.00 |
EPS(TTM) | 0.23 |
P/B Ratio | 19.21 |
Dividend Yield | 0.00% |
Industry P/E | 40.92 |
Book Value | 7.84 |
Debt to Equity | 0.00 |
Face Value | 10 |
Parent Organisation | Mahavir Advanced Remedies Limited |
Managing Director | Mr. BVS Rao |
Founded | 1992 |
COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
---|---|---|---|---|
Torrent Pharmaceuticals | NA (0.00%) | 60.91 | ||
Ajanta Pharma | NA (0.00%) | 36.65 | ||
Gland Pharma | NA (0.00%) | 44.72 | ||
Eris Lifesciences | NA (0.00%) | 67.90 |